Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
IGC | US
0.00
0.06%
Healthcare
Drug Manufacturers-Specialty & Generic
30/06/2024
13/09/2024
0.36
0.36
0.37
0.36
IGC Pharma Inc. a clinical stage biotechnology company engages in developing cannabinoid-based formulations for treating diseases and conditions including Alzheimer's disease dysmenorrhea premenstrual syndrome and chronic pain. The company has two investigational drug assets targeting Alzheimer's disease comprising IGC-AD1 which is in a Phase 2B clinical trial as a treatment for agitation in dementia due to Alzheimer's; and TGR-63 that is in pre-clinical development. It also markets Holief a wellness brand that targets women experiencing premenstrual syndrome and menstrual cramps. The company was formerly known as India Globalization Capital Inc. and changed its name to IGC Pharma Inc. in March 2023. The company was incorporated in 2005 and is headquartered in Potomac Maryland.
View LessLow Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
44.3%1 month
51.4%3 months
94.0%6 months
108.1%-
-
3.39
0.04
0.03
-2.54
23.74
-
-9.40M
26.45M
26.45M
-
-871.32
-
-51.00
-126.20
5.67
2.33
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
0.05
Range1M
0.12
Range3M
0.22
Rel. volume
0.35
Price X volume
46.10K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Lipocine Inc | LPCN | Drug Manufacturers-Specialty & Generic | 4.61 | 25.12M | 12.99% | n/a | 0.00% |
MEI Pharma Inc | MEIP | Drug Manufacturers-Specialty & Generic | 3.03 | 20.19M | -0.98% | 0.79 | 22.86% |
Cumberland Pharmaceuticals Inc | CPIX | Drug Manufacturers-Specialty & Generic | 1.29 | 17.85M | -0.77% | n/a | 81.86% |
Flora Growth Corp. Common Stock | FLGC | Drug Manufacturers-Specialty & Generic | 0.968 | 12.51M | 4.09% | n/a | 76.81% |
Guardion Health Sciences Inc | GHSI | Drug Manufacturers-Specialty & Generic | 9.91 | 12.16M | -2.08% | n/a | 0.00% |
Universe Pharmaceuticals INC | UPC | Drug Manufacturers-Specialty & Generic | 0.544 | 11.48M | -67.43% | n/a | 13.87% |
Biofrontera Inc. Common Stock | BFRI | Drug Manufacturers-Specialty & Generic | 1.29 | 7.28M | 4.88% | n/a | 13.20% |
Imc Mortgage Co | IMCC | Drug Manufacturers-Specialty & Generic | 2.29 | 4.84M | -2.14% | n/a | 222.75% |
Avenue Therapeutics Inc | ATXI | Drug Manufacturers-Specialty & Generic | 2.81 | 4.48M | 0.36% | 0.08 | 0.00% |
PETROS PHARMACEUTICALS INC | PTPI | Drug Manufacturers-Specialty & Generic | 0.3643 | 3.58M | -0.84% | n/a | 83.11% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
REE Automotive Ltd. Class A Ordinary Shares | REE | Recreational Vehicles | 2.965 | 26.61M | -13.30% | n/a | 54.96% |
ILAG | ILAG | Building Products & Equipment | 1.1699 | 20.96M | -0.85% | n/a | 5.48% |
The Dixie Group Inc | DXYN | Textile Manufacturing | 0.7456 | 10.41M | 7.76% | n/a | 422.08% |
Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 1.07 | 10.31M | 35.44% | n/a | 16.03% |
Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.5337 | 4.94M | 18.60% | n/a | 19.98% |
EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.31 | 3.62M | 1.55% | n/a | 9.62% |
Forza X1 Inc | FRZA | Recreational Vehicles | 0.2475 | 3.40M | 15.12% | n/a | 0.97% |
Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 0.7797 | 447.17K | -48.02% | n/a | 0.00% |
Blackstone/GSO Senior Floating Rate Term Fund | BSL | Textile Manufacturing | 14.21 | 0 | -0.28% | n/a |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -2.54 | - | Cheaper |
Ent. to Revenue | 23.74 | - | Cheaper |
PE Ratio | - | 28.13 | - |
Price to Book | 3.39 | 11.07 | Cheaper |
Dividend Yield | - | - | - |
Std. Deviation (3M) | 93.99 | - | Riskier |
Debt to Equity | 0.04 | -0.91 | Expensive |
Debt to Assets | 0.03 | 0.45 | Cheaper |
Market Cap | 26.45M | - | Emerging |